We are live on ! Find out more
CVS icon

CVS Health

1,419 hedge funds and large institutions have $92.4B invested in CVS Health in 2014 Q4 according to their latest regulatory filings, with 184 funds opening new positions, 490 increasing their positions, 601 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

338% more first-time investments, than exits

New positions opened: 184 | Existing positions closed: 42

44% more funds holding in top 10

Funds holding in top 10: 140201 (+61)

20% more capital invested

Capital invested by funds: $77.1B → $92.4B (+$15.3B)

10% more funds holding

Funds holding: 1,2921,419 (+127)

0.04% more ownership

Funds ownership: 83.87%83.91% (+0.04%)

3% less call options, than puts

Call options by funds: $406M | Put options by funds: $419M

18% less repeat investments, than reductions

Existing positions increased: 490 | Existing positions reduced: 601

Holders
1,419
Holders Change
+127
Holders Change %
+9.83%
% of All Funds
37.83%
Holding in Top 10
201
Holding in Top 10 Change
+61
Holding in Top 10 Change %
+43.57%
% of All Funds
5.36%
New
184
Increased
490
Reduced
601
Closed
42
Calls
$406M
Puts
$419M
Net Calls
-$12.7M
Net Calls Change
-$2.29M
Name Holding Trade Value Shares
Change
Change in
Stake
MYLI
651
Meiji Yasuda Life Insurance
Japan
$4.43M -$337K -3,830 -8%
1SB
652
1ST Source Bank
Indiana
$4.39M +$160K +1,821 +4%
NME
653
Notis-McConarty Edward
$4.39M +$13.2K +150 +0.3%
Cambridge Investment Research Advisors
654
Cambridge Investment Research Advisors
Iowa
$4.38M +$370K +4,194 +10%
BAM
655
Burnham Asset Management
New York
$4.36M -$1.76M -19,925 -31%
SAM
656
Solaris Asset Management
New York
$4.35M +$28.6K +325 +0.7%
CA
657
Cullinan Associates
Kentucky
$4.35M +$635K +7,205 +19%
DBG
658
De Burlo Group
Massachusetts
$4.33M +$3.63M +41,200 +1,083%
FSA
659
Financial Sense Advisors
California
$4.33M -$1.16M -13,176 -23%
DADC
660
D.A. Davidson & Co
Montana
$4.33M -$356K -4,038 -8%
CBB
661
Citizens Business Bank
California
$4.29M +$136K +1,540 +4%
PAI
662
Pittenger & Anderson Inc
Nebraska
$4.29M +$190K +2,155 +5%
UAS
663
United Asset Strategies
New York
$4.29M -$3.61K -41 -0.1%
CVM
664
Cheviot Value Management
California
$4.28M +$42.6K +483 +1%
KIA
665
KCM Investment Advisors
California
$4.26M -$1.41K -16 -0%
SIC
666
Salem Investment Counselors
North Carolina
$4.26M -$111K -1,261 -3%
SAMNY
667
Samsung Asset Management (New York)
New York
$4.25M -$288K -3,270 -7%
TSWM
668
Triangle Securities Wealth Management
North Carolina
$4.22M +$145K +1,650 +4%
LPT
669
Legacy Private Trust
Wisconsin
$4.22M +$1.53M +17,421 +66%
BPCA
670
Bank Pictet & Cie (Asia)
Singapore
$4.2M -$131K -1,490 -3%
FC
671
Forte Capital
New York
$4.15M -$11.9K -135 -0.3%
PPSG
672
Princeton Portfolio Strategies Group
New Jersey
$4.12M -$24.2K -275 -0.6%
CPS
673
Counsel Portfolio Services
Ontario, Canada
$4.09M +$204K +2,316 +6%
CCT
674
Capital City Trust
Florida
$4.09M +$39.6K +450 +1%
NEAM
675
New England Asset Management
Connecticut
$4.07M -$5.69M -64,632 -60%

CVS Hedge Fund Activity: Q4 2014 in Review

1,419 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q4 2014, worth a combined $92.4B — up 20% from $77.1B a quarter earlier.

Buyers outnumbered sellers: 184 funds opened new CVS positions and 42 closed out — a net gain of 142 holders — while 490 added to existing stakes and 601 trimmed.

The largest buyer was Capital World Investors, adding an estimated $340M. The largest seller was Institutional Capital, exiting entirely with an estimated $373M sold.

  • 1,419 institutional investors held CVS Health (CVS) as of Q4 2014, up from 1,292 in Q3 2014.
  • Funds reported $92.4B of CVS Health stock for Q4 2014, up 20% quarter-over-quarter.
  • 184 funds opened new CVS Health positions in Q4 2014 and 42 closed out, a net change of +142 holders.
  • The largest CVS Health buyer in Q4 2014 was Capital World Investors, an estimated $340M added.
  • The largest CVS Health seller in Q4 2014 was Institutional Capital, an estimated $373M sold.

Based on aggregated 13F filings for Q4 2014.